Hepatitis C - DAAs reduces the risk of mortality in the first 18 months after the completion of treatment - Hallo friend NEWS AN INSPIRATION, In the article you read this time with the title Hepatitis C - DAAs reduces the risk of mortality in the first 18 months after the completion of treatment, we have prepared well for this article you read and download the information therein. hopefully fill posts Article ECONOMY, Article HEALTH, Article POLITICS, Article SPORTS, Article TRAVELING, Article UPDATE, we write can understand. Well, happy reading.

Titre : Hepatitis C - DAAs reduces the risk of mortality in the first 18 months after the completion of treatment
link : Hepatitis C - DAAs reduces the risk of mortality in the first 18 months after the completion of treatment

Hepatitis C - DAAs reduces the risk of mortality in the first 18 months after the completion of treatment

Source - infohep

Treatment with DAAs reduces the risk of mortality in the first 18 months after the completion of treatment

Michael Carter

Published:10 August 2017

The study – published in Clinical Infectious Diseases – matched people who received therapy with all-DAA regimens with untreated controls. Mortality rates in the first 18 months after therapy were significantly lower among people who received DAAs. After controlling for other factors, treatment with DAAs was associated with a 57% reduction in the risk of death.

“To our knowledge, this is the first large-scale study to demonstrate the effect of newer DAA regimens upon survival,” write the authors. “Treatment with 2 commonly used DAA regimens…was associated with significant improvements in survival within the first 18 months of treatment, compared with demographically and clinically similar untreated HCV-infected controls.”
Continue reading.....

View full text article online at NATAP

Effect of paritaprevir/ritonavir/ombitasvir/dasabuvir and ledipasvir/sofosbuvir regimens on survival compared with untreated hepatitis C virus-infected persons: results from ERCHIVES

Thus articles Hepatitis C - DAAs reduces the risk of mortality in the first 18 months after the completion of treatment

that is all articles Hepatitis C - DAAs reduces the risk of mortality in the first 18 months after the completion of treatment This time, hopefully can provide benefits to you all. Okay, see you in another article post.

You are now reading the article Hepatitis C - DAAs reduces the risk of mortality in the first 18 months after the completion of treatment the link address https://newsaninpiration.blogspot.com/2017/08/hepatitis-c-daas-reduces-risk-of.html

Tweet

Subscribe to receive free email updates: